Medtronic plc. (MDT)

NYSE: MDT · IEX Real-Time Price · USD
+0.80 (1.03%)
Dec 9, 2022 4:00 PM EST - Market closed
Market Cap 103.47B
Revenue (ttm) 30.81B
Net Income (ttm) 4.32B
Shares Out 1.33B
EPS (ttm) 3.22
PE Ratio 24.41
Forward PE 14.88
Dividend $2.62 (3.33%)
Ex-Dividend Date Sep 22, 2022
Volume 5,987,202
Open 77.77
Previous Close 77.79
Day's Range 77.3 - 78.92
52-Week Range 75.83 - 114.31
Beta 0.74
Analysts Buy
Price Target 95.77 (+21.9%)
Earnings Date Nov 22, 2022

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]

Industry Health Care Equipment & Supplies
Founded 1949
CEO Geoffrey Martha
Employees 95,000
Stock Exchange NYSE
Ticker Symbol MDT
Full Company Profile

Financial Performance

In 2022, Medtronic plc.'s revenue was $31.69 billion, an increase of 5.21% compared to the previous year's $30.12 billion. Earnings were $5.04 billion, an increase of 39.74%.

Financial Statements

Analyst Forecast

According to 34 analysts, the average rating for MDT stock is "Buy." The 12-month stock price forecast is 95.77, which is an increase of 21.86% from the latest price.

Price Target
(21.86% upside)
Analyst Consensus: Buy
Stock Forecasts


Medtronic: Income Investor's Delight Available at a Discount

Medtronic PLC ( MDT , Financial) is an attractive stock for investors looking for solid and profitable options. The broad portfolio of medical devices, medications and services has been the driving forc...

6 hours ago - GuruFocus

Medtronic announces cash dividend for third quarter of fiscal year 2023

DUBLIN , Dec. 8, 2022 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 8, 2022, approved the fiscal year 2023 third quarter cash dividend of $0.68 per ordinary sh...

1 day ago - PRNewsWire

My 3 Favorite Stocks Right Now

I'm a fan of stocks with historically high yields and businesses built for the long term.

Other symbols: MMMTXN
2 days ago - The Motley Fool

Medtronic completes enrollment in pivotal trial evaluating first-of-its-kind pulsed field ablation catheter for patie...

SPHERE Per-AF will determine the safety and effectiveness of the Sphere-9 cardiac ablation and mapping catheter with the Affera mapping and navigation system DUBLIN , Dec. 5, 2022 /PRNewswire/ -- Medtro...

4 days ago - PRNewsWire

7 Excellent Dividend Stocks to Buy for the Holiday Season

With the holiday season upon us, investors may want to focus largely on dividend stocks to buy. While growth-oriented names provide the most excitement, market participants must acknowledge reality.

1 week ago - InvestorPlace

3 High-Yielding Dividend Stocks Near Their 52-Week Lows

The lowest yield on this list is 2.7%.

Other symbols: PSASO
1 week ago - The Motley Fool

Should You Buy Medtronic Stock At $80?

The recent fall can be attributed to the Q2FY23 results the company reported yesterday, with revenue falling below and earnings above our estimates.

2 weeks ago - Forbes

Medtronic executives to speak at the Evercore ISI 5th annual HealthCONx conference

DUBLIN , Nov. 23, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the Evercore ISI 5th annual HealthCONx conference on Tue...

2 weeks ago - PRNewsWire

Medtronic Stock Falls After Medical-Device Maker Posts Lower Earnings

Supply-chain and demand challenges pressure the Dublin-based company's latest quarterly results.

2 weeks ago - WSJ

These 2 Stocks Just Made Surprising Moves

Markets had a strong day.

Other symbols: ADI
2 weeks ago - The Motley Fool

Medtronic (MDT) Q2 Earnings Beat Estimates, Margins Down

Medtronic's (MDT) Q2 organic revenues reflect slower supply recovery and lower-than-anticipated underlying market procedure volumes in certain businesses.

2 weeks ago - Zacks Investment Research

Medtronic (MDT) Q2 Earnings Surpass Estimates

Medtronic (MDT) delivered earnings and revenue surprises of 1.56% and 1.72%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

Medical Behemoth Medtronic Crumbles After Missing Its Own Guidance

Medtronic reported mixed earnings and lighter-than-expected organic sales growth, leading MDT stock to tumble. The post Medical Behemoth Medtronic Crumbles After Missing Its Own Guidance appeared first ...

2 weeks ago - Investors Business Daily

Medtronic Lowers Earnings Guidance, Citing Slower Procedure and Supply Recovery

The medical device maker misses fiscal second-quarter sales expectations and lowers its earnings guidance for the year.

2 weeks ago - Barrons

Medtronic stock falls after profit beats expectations but revenue misses, and outlook is downbeat

Shares of Medtronic PLC MDT, +1.22% dropped 2.4% in premarket trading Tuesday, after the medical devices maker reported fiscal second-quarter profit that topped expectations but revenue that missed and ...

2 weeks ago - Market Watch

Medtronic reports second quarter fiscal 2023 financial results

Earnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes DUBLIN , Nov. 22, 2022 /PRNewswire/ -- Medtronic...

2 weeks ago - PRNewsWire

4 No-Brainer Dividend Stocks for the End of 2022

The end of the year is usually an excellent time to look for deals. In 2022, a bear market caused by rising interest rates in response to the highest inflation in four decades punished stock prices.

Other symbols: MSFTPGVZ
2 weeks ago - InvestorPlace

3 Top Dividend Stocks to Buy Now With Yields of 3.4% or More

These stocks offer attractive yields now, and investors can look forward to lots of payout raises.

Other symbols: ABBVALLY
2 weeks ago - The Motley Fool

3 Unstoppable Growth Stocks to Buy and Hold for the Next Decade

These impressive businesses seem to have plenty of room for further growth.

Other symbols: MDBSQ
2 weeks ago - The Motley Fool

What's in the Cards for Medtronic (MDT) in Q2 Earnings?

Medtronic's (MDT) Evolut PRO+ launch in Europe and Evolut PRO launch in China are expected to have contributed to the company's fiscal Q3 top line.

3 weeks ago - Zacks Investment Research

Will Medtronic Stock See Higher Levels Post Q2 Results?

Medtronic (NYSE: MDT) is scheduled to report its fiscal 2023 second-quarter results on Tuesday, November 22. We expect Medtronic to post revenues and earnings in line with the street estimates.

3 weeks ago - Forbes

6 Healthcare Stocks With Room to Climb

Zoetis and Medtronic are among the healthcare stocks with the most room to rise, according to Wall Street analysts' average price targets.

3 weeks ago - Barrons

Op-ed: Here are 6 stocks with excellent vital signs in the health-care sector

Here are six health-care stocks with low-risk fundamentals, reasonable debt, good price-earnings ratios, sanguine growth projections and healthy yields.

3 weeks ago - CNBC

Medtronic to announce financial results for its second quarter of fiscal year 2023

DUBLIN , Nov. 15, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 202...

3 weeks ago - PRNewsWire

Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.

Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set DUBLIN , Nov. 15, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leade...

3 weeks ago - PRNewsWire